Abbvie

Article

What will the Intermune and Abbvie cases mean for the medical devices industry?

I have just written annotations to the Abbvie and Intermune cases under EU pharmaceutical law for the next issue of the Dutch legal journal Jurisprudentie Geneesmiddelenrecht (in Dutch, sorry) but of course that…

Navigate through our knowledgebase